JP2023519362A5 - - Google Patents
Info
- Publication number
- JP2023519362A5 JP2023519362A5 JP2022558347A JP2022558347A JP2023519362A5 JP 2023519362 A5 JP2023519362 A5 JP 2023519362A5 JP 2022558347 A JP2022558347 A JP 2022558347A JP 2022558347 A JP2022558347 A JP 2022558347A JP 2023519362 A5 JP2023519362 A5 JP 2023519362A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- amino
- triazolo
- pyrimidine
- pyridyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062994908P | 2020-03-26 | 2020-03-26 | |
| US62/994,908 | 2020-03-26 | ||
| PCT/EP2021/057806 WO2021191378A1 (en) | 2020-03-26 | 2021-03-25 | 5-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one compounds for use against cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023519362A JP2023519362A (ja) | 2023-05-10 |
| JP2023519362A5 true JP2023519362A5 (https=) | 2024-04-01 |
| JP7675094B2 JP7675094B2 (ja) | 2025-05-12 |
Family
ID=75339740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022558347A Active JP7675094B2 (ja) | 2020-03-26 | 2021-03-25 | トリアゾロン化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230271964A1 (https=) |
| EP (1) | EP4126872A1 (https=) |
| JP (1) | JP7675094B2 (https=) |
| KR (1) | KR20230049579A (https=) |
| CN (1) | CN115867282B (https=) |
| AU (1) | AU2021240344A1 (https=) |
| CA (1) | CA3176944A1 (https=) |
| WO (1) | WO2021191378A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3243621A1 (en) * | 2022-02-01 | 2023-08-10 | Eli Lilly And Company | METHODS FOR PREPARING SELECTIVE ESTROGEN RECEPTOR DEGRADING AGENTS |
| JP2025512384A (ja) | 2022-04-13 | 2025-04-17 | ギリアード サイエンシーズ， インコーポレイテッド | Ｔｒｏｐ－２発現がんを治療するための併用療法 |
| WO2025137640A1 (en) | 2023-12-22 | 2025-06-26 | Gilead Sciences, Inc. | Azaspiro wrn inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7452892B2 (en) | 2005-06-17 | 2008-11-18 | Bristol-Myers Squibb Company | Triazolopyrimidine cannabinoid receptor 1 antagonists |
| ATE457988T1 (de) | 2006-06-26 | 2010-03-15 | Schering Corp | A2a-adenosin-rezeptor-antagonisten |
| JP2011513417A (ja) | 2008-03-04 | 2011-04-28 | シェーリング コーポレイション | アデノシンＡ２ａ受容体アンタゴニストとして使用するための１，２，４−トリアゾロ［４，３−ｃ］ピリミジン−３−オンおよびピラゾロ［４，３−ｅ］−１，２，４−トリアゾロ［４，３−ｃ］ピリミジン−３−オン化合物 |
| AU2011306358B2 (en) | 2010-09-24 | 2014-08-14 | Impetis Biosciences Ltd. | Fused tricyclic compounds as adenosine receptor antagonist |
| EP3277689B1 (en) | 2015-04-03 | 2019-09-04 | Incyte Corporation | Heterocyclic compounds as lsd1 inhibitors |
| AU2018233367B2 (en) | 2017-03-16 | 2021-08-12 | Jiangsu Hengrui Medicine Co., Ltd. | Heteroaryl[4,3-c]pyrimidine-5-amine derivative, preparation method therefor, and medical uses thereof |
-
2021
- 2021-03-25 WO PCT/EP2021/057806 patent/WO2021191378A1/en not_active Ceased
- 2021-03-25 CA CA3176944A patent/CA3176944A1/en active Pending
- 2021-03-25 CN CN202180038001.3A patent/CN115867282B/zh active Active
- 2021-03-25 AU AU2021240344A patent/AU2021240344A1/en active Pending
- 2021-03-25 EP EP21715861.7A patent/EP4126872A1/en active Pending
- 2021-03-25 JP JP2022558347A patent/JP7675094B2/ja active Active
- 2021-03-25 US US17/914,245 patent/US20230271964A1/en active Pending
- 2021-03-25 KR KR1020227037221A patent/KR20230049579A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12247027B2 (en) | P2X7 modulators | |
| AU2022201413B9 (en) | Fused ring compounds | |
| JP2023519362A5 (https=) | ||
| ES2543903T3 (es) | Pirrolo[2,3-b]piridinas y pirrolo[2,3-b]pirimidinas sustituidas con heteroarilo como inhibidores de quinasas Janus | |
| AU2010310786B2 (en) | AKT inhibitors | |
| FI3932919T3 (fi) | Jak-inhibiittoriyhdiste ja sen käyttö | |
| WO2017087905A1 (en) | Compound, compositions, and methods | |
| JP2019504821A5 (https=) | ||
| JP2024505652A (ja) | Ｃｂｌ－ｂ阻害剤としてのラクタム | |
| US12263171B2 (en) | 7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use | |
| RU2018123779A (ru) | Новые соединения | |
| JP2019517548A5 (https=) | ||
| JP2013523884A5 (https=) | ||
| JP2022500402A5 (https=) | ||
| EP3697410B1 (en) | Benzimidazole derivatives and their uses | |
| CN115697991A (zh) | 哌嗪环状脲 | |
| AU2016322848A1 (en) | 1-phenylpyrrolidin-2-one derivatives as perk inhibitors | |
| JP2023539985A5 (https=) | ||
| US20250326753A1 (en) | Dual cxcr4-btk inhibitors | |
| US20220340544A1 (en) | Substituted heterocyclic derivatives as pi3k inhibitors | |
| JP7681116B2 (ja) | カルボニル置換ジアザスピロ化合物及びその使用 | |
| JP2023519362A (ja) | トリアゾロン化合物 | |
| JP2009500366A5 (https=) | ||
| JP2023519363A5 (https=) | ||
| TWI921912B (zh) | Fgfr抑制劑及其使用方法 |